Back to Browse Journals » Research and Reports in Urology » Volume 3

Role of HMG-CoA reductase inhibitors with curative radiotherapy in men with prostate cancer

Authors Solanki AA, Liauw SL

Published Date June 2011 Volume 2011:3 Pages 95—104


Published 15 June 2011

Abhishek A Solanki, Stanley L Liauw
Department of Radiation and Cellular Oncology, University of Chicago Medical Center, Chicago, IL, USA

Abstract: Brachytherapy and external beam radiotherapy are effective and commonly used treatment modalities in men with localized prostate cancer. In this review, we explore the role of radiation therapy in the curative management of prostate cancer, including the use of conformal therapeutic techniques to allow for the escalation of radiation doses to tumor, along with the use of combined radiation and hormonal therapy to enhance disease outcomes in men with aggressive disease. We also review the possible anticancer role of HMG-CoA reductase inhibiting agents (statins) in men with prostate cancer. Laboratory evidence suggests that statins may have antineoplastic effects when used alone and may sensitize cells to radiation therapy when given in combination. We explore the biologic basis for an anticancer effect and the clinical evidence suggesting statins may aid in improving outcomes with radiation therapy for localized prostate cancer.

HMG-CoA reductase inhibitors, statins, radiotherapy, prostate cancer

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other articles by this author:

Readers of this article also read:

The skin landscape in diabetes mellitus. Focus on dermocosmetic management

Piérard GE, Seité S, Hermanns-Lê T, Delvenne P, Scheen A, Piérard-Franchimont C

Clinical, Cosmetic and Investigational Dermatology 2013, 6:127-135

Published Date: 15 May 2013

Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis

Miyoshi S, Hamada H, Ito R, Katayama H, Irifune K, Suwaki T, Nakanishi N, Kanematsu T, Dote K, Aibiki M, Okura T, Higaki J

Drug Design, Development and Therapy 2013, 7:305-316

Published Date: 10 April 2013

Procalcitonin as an indicator of urosepsis

Sugimoto K, Adomi S, Koike H, Esa A

Research and Reports in Urology 2013, 5:77-80

Published Date: 26 March 2013

The evolving role of hyaluronic acid fillers for facial volume restoration and contouring: a Canadian overview

Muhn C, Rosen N, Solish N, Bertucci V, Lupin M, Dansereau A, Weksberg F, Remington BK, Swift A

Clinical, Cosmetic and Investigational Dermatology 2012, 5:147-158

Published Date: 5 October 2012

Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection

Schroecksnadel S, Kurz K, Weiss G, Fuchs D

Neurobehavioral HIV Medicine 2012, 4:1-13

Published Date: 16 January 2012

Multiple pregnancies and its relationship with the development of retinopathy of prematurity (ROP)

Motta MMS, Fortes Filho JB, Coblentz J, Fiorot CA

Clinical Ophthalmology 2011, 5:1783-1787

Published Date: 20 December 2011

The ADOPT trial (Assessment of Efficacies of Cardiac Resynchronization Therapies (CRT-P/D) for Heart Failure Patients in China): rationale, design, and end-points

Liu B, Yi F, Cai H, Guo W, Li W, Shen M, Xia J, Liu L, Wang H, for the ADOPT Study Steering Committee and Investigators

Open Access Journal of Clinical Trials 2011, 3:35-41

Published Date: 20 June 2011

Training and professional profile of retinologists in Spain: Retina 2 project, Report 4

Pastor JC, Fernández I, Rojas J, Coco R, Sanabria MR, Rodríguez-de la Rúa E, Sánchez D, Valverde C, Sala-Puigdollers A

Clinical Ophthalmology 2011, 5:483-490

Published Date: 21 April 2011